125 Participants Needed

Exercise for Alzheimer's Disease

(RAATE Trial)

MH
Overseen ByMelissa Harris, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Pennington Biomedical Research Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how physical activity affects Alzheimer's risk factors in older African American adults. It aims to determine if a tailored exercise program can improve memory and brain function related to Alzheimer's. Participants will either follow a moderate to vigorous exercise routine or engage in low-intensity activities with healthy aging education. Suitable candidates have not been regularly active, are African American, and have no conditions that make exercise unsafe. As an unphased trial, this study offers a unique opportunity to contribute to important research on Alzheimer's prevention in the community.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this physical activity intervention is safe for older African American adults?

Research has shown that physical activity benefits brain health and may lower the risk of Alzheimer's disease. Studies have found that regular exercise can reduce the chance of developing dementia by up to 20%. Those engaging in moderate to vigorous exercise face an even lower risk.

Exercise also boosts thinking skills, including awareness, perception, reasoning, and judgment. For older adults, staying active helps maintain these skills. Evidence suggests that exercise might also assist with daily tasks for those with Alzheimer's.

Regarding safety, physical activity is generally safe and does not involve surgery or entering the body. It lacks the side effects associated with medications. Most people can safely begin a regular exercise routine, but consulting a healthcare provider before starting any new program is advisable.12345

Why are researchers excited about this trial?

Researchers are excited about using physical activity as a treatment for Alzheimer's disease because it offers a non-pharmacological approach that could complement or even enhance existing treatments like cholinesterase inhibitors and NMDA receptor antagonists. Unlike medications that focus primarily on chemical interactions in the brain, this approach aims to improve cognitive function and overall health through increased blood flow and neuroplasticity resulting from aerobic and strength training exercises. This method also empowers patients to take an active role in their treatment by incorporating manageable lifestyle changes, potentially leading to improved quality of life and reduced symptoms without the side effects commonly associated with medications.

What evidence suggests that physical activity could be an effective treatment for Alzheimer's Disease?

Research has shown that physical activity can enhance brain function in people with Alzheimer's Disease. In this trial, participants in the physical activity intervention arm will engage in moderate to vigorous aerobic exercise and strength training. Previous studies suggest these activities might slow the decline in thinking skills for those with this condition. One study discovered that regular exercise could lower the risk of developing dementia by up to 20%. Engaging in moderate to vigorous physical activity may also lead to a 60% decrease in dementia risk. Overall, evidence suggests that staying active benefits brain health and may help manage Alzheimer's Disease.23678

Who Is on the Research Team?

RL

Robert L Newton, Jr., PhD

Principal Investigator

Pennington Biomedical Research Center

OL

Owen Carmichael, PhD

Principal Investigator

Pennington Biomedical Research Center

Are You a Good Fit for This Trial?

The RAATE trial is for African American adults aged 60 and older who are not currently exercising regularly. Participants must be physically able to exercise, willing to attend group sessions, and have no plans to move during the study. They should not have cognitive impairments that interfere with group interactions or any medical conditions that make regular exercise unsafe.

Inclusion Criteria

You are able to do physical activity.
Lacking plans to move during the study period
My physical ability score is 4 or higher.
See 6 more

Exclusion Criteria

You have health issues that make it hard for you to exercise regularly.
Conditions that the medical or principal investigator determine to warrant exclusion
I do not have any cognitive issues that would prevent me from participating in group activities.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are randomized into a physical activity promotion intervention or a healthy aging information group for 52 weeks

52 weeks
2 visits per week (in-person for supervised activity)

Follow-up

Participants are monitored for changes in cognitive function, brain structure, and other health parameters

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Physical activity
  • Successful Aging
Trial Overview This trial tests if a physical activity program can affect risk factors for Alzheimer's Disease in older African Americans. It compares this program against an active control group, focusing on changes in cognitive function, brain structure and function, as well as physiological parameters like blood pressure and fitness levels.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Physical activity interventionExperimental Treatment1 Intervention
Group II: Active controlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Pennington Biomedical Research Center

Lead Sponsor

Trials
314
Recruited
183,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Published Research Related to This Trial

A 16-week supervised aerobic exercise program for 200 patients with mild Alzheimer's disease did not show significant improvements in overall cognitive performance or quality of life compared to a control group.
However, the exercise program significantly reduced neuropsychiatric symptoms and showed potential cognitive benefits in patients who adhered closely to the exercise regimen, indicating that regular, intense exercise may help improve certain aspects of cognitive function in this population.
Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial.Hoffmann, K., Sobol, NA., Frederiksen, KS., et al.[2022]
A year-long exercise program for patients with Alzheimer's disease (AD) showed that those participating in group-based or home-based exercise experienced slower deterioration in physical functioning compared to a control group receiving usual care.
The exercise groups also had significantly fewer falls and did not incur higher costs for health and social services, suggesting that intense exercise can be a safe and effective intervention for improving mobility in AD patients.
Effects of the Finnish Alzheimer disease exercise trial (FINALEX): a randomized controlled trial.Pitkälä, KH., Pöysti, MM., Laakkonen, ML., et al.[2022]
A 12-week home-based physical activity program for 30 patients with Alzheimer's disease helped maintain their ability to perform daily activities, while the control group showed a decline in performance over the same period.
The intervention also led to improvements in cognitive functions, such as semantic word fluency and reaction time, and helped stabilize caregiver burden, suggesting that physical activity can be beneficial for both patients and their caregivers.
Effects of physical activity training in patients with Alzheimer's dementia: results of a pilot RCT study.Holthoff, VA., Marschner, K., Scharf, M., et al.[2022]

Citations

A meta-analysis of the efficacy of physical exercise ...The results showed that physical exercise might significantly improve ADL in Alzheimer's patients (SMD = 0.33, 95% CI: 0.12–0.54, I2 = 81.7%).
Small Amounts of Moderate to Vigorous Physical Activity Are ...The researchers found dementia risk decreased with higher amounts of physical activity. Dementia risks were 60% lower in participants in the 35 ...
Effectiveness of Physical Exercise on Alzheimer's disease. ...This study suggests a walking-based PE program can stabilize and slow down the progressive cognitive dysfunctions exhibited by individuals with AD and improve ...
Physical activity and the risk of dementiaResearch has shown that people who take regular exercise may be up to 20% less likely to develop dementia than those who don't take regular exercise.
Physical activity can improve cognition in patients with ...This meta-analysis and systematic review indicated that exercise intervention might improve the cognitive function of AD or slow down the decline of cognition.
Physical exercise in the prevention and treatment of ...Low levels of physical activity are a risk factor associated with Alzheimer's disease. Older adults who exercise are more likely to maintain cognition.
How exercise can protect against Alzheimer'sExercise has well-known protective effects in Alzheimer's disease (AD). More exercise is associated with lower risk of AD, better cognitive function, and less ...
A meta-analysis of the efficacy of physical exercise ...The results showed that physical exercise might significantly improve ADL in Alzheimer's patients (SMD = 0.33, 95% CI: 0.12–0.54, I2 = 81.7%). Sensitivity ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security